Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Potassium Binders: Safety Comes First!
Javed Butler, MD, MPH, MBA
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
James Burton, DM, FRCP
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Breaking New Ground: Acoramidis Reduces AF Events in ATTR CM Patients from ESC Heart Failure 2025
Kevin Alexander, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
Difelikefalin: Managing CKD-aP for Improved Quality of Life
Jörg Latus, MD
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
Ahmad Masri, MD, MS
Epilepsy: Beyond Seizure Impact
Raman Sankar, MD, PhD
Scott Aaronson, MD
VNS: Beyond Seizure Control
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
Optimizing VNS Parameters: Keys to Therapeutic Success
FSGS in Practice: Patient-Centered Decision-Making
Kenneth Lieberman, MD
Howard Trachtman, MD, FASN
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Don't Miss It! Rapid & Accurate AAV Diagnosis
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD